The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders
The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Background: Mood disorders, especially bipolar disorder (BD), frequently are associated with substance use disorders (SUDs). There are well-designed trials for the treatment of SUDs in the absence of a comorbid condition. However, one cannot generalize these study results to individuals with comorbid mood disorders, because therapeutic efficacy and/or safety and tolerability profiles may differ with the presence of the comorbid disorder. Therefore, a review of the available evidence is needed to provide guidance to clinicians facing the challenges of treating patients with comorbid mood disorders and SUDs. Methods: We reviewed the literature published between January 1966 and November 2010 by using the following search strategies on PubMed. Search terms were bipolar disorder or depressive disorder, major (to exclude depression, postpartum; dysthymic disorder; cyclothymic disorder; and seasonal affective disorder) cross-referenced with alcohol or drug or substance and abuse or dependence or disorder . When possible, a level of evidence was determined for each treatment using the framework of previous Canadian Network for Mood and Anxiety Treatments recommendations. The lack of evidence-based literature limited the authors’ ability to generate treatment recommendations that were strictly evidence based, and as such, recommendations were often based on the authors’ opinion. Results: Even though a large number of treatments were investigated for alcohol use disorder (AUD), none have been sufficiently studied to justify the attribution of level 1 evidence in comorbid AUD with major depressive disorder (MDD) or BD. The available data allows us to generate first-choice recommendations for AUD comorbid with MDD and only third-choice recommendations for cocaine, heroin, and opiate SUD comorbid with MDD. No recommendations were possible for cannabis, amphet-amines, methamphetamines, or polysubstance SUD comorbid with MDD. First-choice recommendations were possible for alcohol, cannabis, and cocaine SUD comorbid with BD and only second-choice recommendations for heroin, amphetamine, methamphetamine, and polysubstance SUD comorbid with BD. No recommendations were possible for opiate SUD comorbid with BD. Finally, psychotherapies certainly are considered an essential component of the overall treatment of SUDs comorbid with mood disorders. However, further well-designed studies are needed in order to properly assess their potential role in specific SUDs comorbid with a mood disorder. Conclusions: Although certain treatments show promise in the management of mood disorders comorbid with SUDs, additional well-designed studies are needed to properly assess their potential role in specific SUDs comorbid with a mood disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering that comorbid presentations tend to be linked to more severe impairment (Kessler, Chiu et al., 2005) and are more difficult to treat (Beaulieu et al., 2012)”
From Examining psychological inflexibility as a transdiagnostic process across psychological disorders (2014) · cites this paper as Beaulieu et al., 2012
In the citing paper
“and the difficulty in treating these comorbid presentations (Beaulieu et al., 2012)”
From Examining psychological inflexibility as a transdiagnostic process across psychological disorders (2014) · cites this paper as Beaulieu et al., 2012
In the citing paper
“CBT is also effective for depressive symptoms in substance use disorders”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [23]
In the citing paper
“Level 2 Evidence supports integrated psychosocial treatment of alcohol misuse and depression.”
From Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder (2016) · cites this paper as [23]
Citations
Cites
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Mental Health: A Report of the Surgeon General
(1999) · PsycEXTRA Dataset · doi:10.1037/e636982009-001 · Cited by 3,097
Depression and cancer mortality: a meta-analysis
Pinquart, M., & Duberstein, P. R. (2010) · Psychological Medicine · doi:10.1017/s0033291709992285 · Cited by 1,083
Kessler, R. C., Nelson, C. B., McGonagle, K. A., Liu, J., Swartz, M., & Blazer, D. G. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298371 · Cited by 1,081
Implementing Dual Diagnosis Services for Clients With Severe Mental Illness
Drake, R. E., Essock, S. M., Shaner, A., Carey, K. B., Minkoff, K., Kola, L., Lynde, D., Osher, F. C., Clark, R. E., & Rickards, L. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.469 · Cited by 693 · cited 1×
“127,128”
The epidemiology of dual diagnosis
Kessler, R. C. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.034 · Cited by 588
GELLER, B., COOPER, T. B., SUN, K., ZIMERMAN, B., FRAZIER, J., WILLIAMS, M., & HEATH, J. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199802000-00009 · Cited by 526
JANE-LLOPIS, E., & MATYTSINA, I. (2006) · Drug and Alcohol Review · doi:10.1080/09595230600944461 · Cited by 497
Drake, R. E., O'Neal, E. L., & Wallach, M. A. (2008) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.01.011 · Cited by 447
Drake, R. E., McHugo, G. J., Clark, R. E., Teague, G. B., Xie, H., Miles, K., & Ackerson, T. H. (1998) · American Journal of Orthopsychiatry · doi:10.1037/h0080330 · Cited by 419 · cited 1×
“Two studies 118,119,124 by the same team compared ACT with standard case management for co-occurring severe mental disorder and active SUD, in a total of 241 patients with MDD with bipolar features, or BD.”
Research works printed but not linked: 1
- 10.1037/1064-1297.10.3.276 · doi:10.1037/1064-1297.10.3.276 · Paper page
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationKennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Self-citationParikh, S. V., Quilty, L. C., Ravitz, P., Rosenbluth, M., Pavlova, B., Grigoriadis, S., Velyvis, V., Kennedy, S. H., Lam, R. W., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659418 · Cited by 562
Examining psychological inflexibility as a transdiagnostic process across psychological disorders
Levin, M. E., MacLane, C., Daflos, S., Seeley, J. R., Hayes, S. C., Biglan, A., & Pistorello, J. (2014) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2014.06.003 · Cited by 400
“, 2005) and are more difficult to treat (Beaulieu et al., 2012), this has potential implications for treatment development and suggests targeting psychological inflexibility may be particularly important for those who are experiencing comorbid problems.”
BackgroundInfluentialFountoulakis, K. N., Grunze, H., Vieta, E., Young, A., Yatham, L., Blier, P., Kasper, S., & Moeller, H. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw109 · Cited by 248
Metadata
- Authors
- Beaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A.
- Affiliations
- Douglas Mental Health University Institute (CA)
- University of Manitoba (CA)
- McGill University (CA)
- University of British Columbia (CA)
- University Health Network (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Beaulieu, Serge
- ORCID
- Venue
- Annals of Clinical Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-02
- Volume
- 24
- Issue
- 1
- Pages
- 38-55
- ISSN
- 1040-1237 (ISSN-L)
- 1547-3325
- OpenAlex
- W4414113943
- Cited by
- 38
- References
- 128
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 5 · 2015: 1 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, major depressive disorder, substance use disorders, comorbidities, alcoholism, cocaine dependence, cannabis use disorder, polysubstance use disorder, treatment guidelines, psychotherapy, safety and tolerability, treatment efficacy, level of evidence
- MeSH terms
- Alcoholism, Anticonvulsants, Antidepressive Agents, Bipolar Disorder, Canada, Major Depressive Disorder, Humans, Opioid-Related Disorders, Psychotherapy, Antipsychotic Agents, Comorbidity, Antimanic Agents, Mood Disorders, Substance-Related Disorders, Cocaine-Related Disorders, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders. https://app.cochat.ai/papers/10.1177/104012371202400105
- The paper
- Beaulieu, S., Saury, S., Sareen, J., Tremblay, J., Schütz, C. G., McIntyre, R. S., & Schaffer, A. (2012). The Canadian Network for Mood and Anxiety Treatments (Canmat) Task Force Recommendations for the Management of Patients with Mood Disorders and Comorbid Substance Use Disorders. Annals of Clinical Psychiatry. https://doi.org/10.1177/104012371202400105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.